All Articles

Artelo Biosciences uses advanced analytics to link its lead drug to a core disease pathway, a strategic move to de-risk development and attract major partners.

For the first time in 25 years, Georgia concrete drivers have unionized. This historic vote with the Teamsters could reshape labor relations in the South.

How an innovative financing tool called C-PACE is reviving a landmark and signaling a new era for urban redevelopment in a tight credit market.

A new study shows Candela's Nordlys laser not only reverses skin aging at a DNA level but may also fight cancer, setting a new bar for the industry.

Beyond the recycling bin, a Kansas City non-profit is proving that large-scale composting is not just sustainable, but essential public infrastructure.

Kao USA's recall of its premium Oribe shampoo over bacterial contamination reveals the hidden operational risks that can undermine even top-tier brands.

The Association for Diagnostics & Laboratory Medicine's new leadership, led by Dr. Christina Lockwood, signals a decisive move to tackle healthcare's biggest challenges.

Hexaware's new Tensai® platform uses reasoning AI agents not just to solve IT problems faster, but to stop them from happening. Is this the dawn of autonomous IT?

With its new Tensai platform, Hexaware is betting that the future of IT isn't faster fixes, but a system that intelligently removes demand altogether.

Serial fitness entrepreneur Jamie Weeks is launching LiftHER, a women's-only strength studio, tackling a multi-billion dollar market where 73% of women are underserved.

Gartner's latest report signals a major shift. It's no longer just about AI writing code; it’s about managing the AI that does. We unpack the new era.

The retailer's back-to-back USA Today awards reveal a potent strategy, but a closer look shows the complex operational machine powering its celebrated success.

Triumph's new RFP Manager moves beyond static benchmarks, leveraging a vast network of live transaction data to give freight brokers confidence in a volatile market.

AstreaX's digital wallet now handles vehicle renewals on your phone. We analyze the tech, the Arizona rollout, and the security needed for true adoption.

NurExone's modest C$628k funding isn't a sign of weakness, but a masterclass in biotech survival. It's a strategic play in a cautious market.

The world's only lupus-focused fund is betting on a new model blending VC rigor with patient-led strategy. But can this ambitious structure deliver real progress?

Sarepta seeks full FDA approval for two Duchenne drugs, leaning on real-world evidence after a key trial missed its goal. A test case for rare disease innovation.

Hong Kong's Mint Inc. aims to fuse AI with chipmaking via a Singapore acquisition, but can its bold vision overcome its financial fragility?

By partnering with manufacturing giant Sanmina, Microbot Medical is telegraphing its shift from a promising MedTech firm to a serious global contender.